Helen Elizabeth Hanby
Directeur/Membre du Conseil chez NIGHTSTAR THERAPEUTICS PLC
Postes actifs de Helen Elizabeth Hanby
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | Directeur/Membre du Conseil | 07/06/2019 | - |
| Secrétaire Général | 08/08/2019 | - | |
Tungsten Bidco Ltd.
 Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Directeur/Membre du Conseil | 04/06/2019 | - |
| Secrétaire Général | 08/08/2019 | - | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 07/06/2019 | - |
| Secrétaire Général | 08/08/2019 | - |
Historique de carrière de Helen Elizabeth Hanby
Statistiques
Internationale
| Royaume-Uni | 4 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Secretary | 3 |
Sectorielle
| Health Technology | 2 |
| Finance | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Finance |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
- Bourse
- Insiders
- Helen Elizabeth Hanby
- Expérience